Kangmei Pharma | 600518 - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Avita Medical AUD -11.64M 12.13M 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Genomma Lab Internacional MXN 644.1M 76.04M 2026-03
Hypermarcas BRL 439.21M 8.9M 2025-12
Ionis Pharmaceuticals USD -93M 135M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
Jiangsu Hengrui CNY 2.56B 261.24M 2026-03
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Moderna USD -799M 612M 2025-12
Organon & Co USD -148M 391M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Sh Fosun Pharma CNY 1.27B 155.78M 2025-12
Tectonic Therapeutic USD -18.97M 63K 2025-12
Viatris USD -343M 335.1M 2025-12
Wuxi Apptec CNY 5.61B 3.26B 2026-03
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03